Sucralfate and Hepatic encephalopathy - a phase IV clinical study of FDA data

Summary:

Hepatic encephalopathy is reported as a side effect among people who take Sucralfate (sucralfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lantus, and have Hepatic neoplasm malignant.

The phase IV clinical study analyzes which people have Hepatic encephalopathy when taking Sucralfate. It is created by eHealthMe based on reports of 17,187 people who have side effects when taking Sucralfate from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Hepatic encephalopathy?

Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure) is found to be associated with 910 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Hepatic encephalopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

17,187 people reported to have side effects when taking Sucralfate.
Among them, 32 people (0.19%) have Hepatic encephalopathy.

Could Sucralfate cause Hepatic encephalopathy?

Among these 32 people:

How long have people been on Sucralfate when they have Hepatic encephalopathy? *

What is the gender of people who have Hepatic encephalopathy when taking Sucralfate? *

female: 25.81 %
male: 74.19 %

What is the age of people who have Hepatic encephalopathy when taking Sucralfate? *

What are other drugs people take besides Sucralfate? *

What are other side effects people have besides Hepatic encephalopathy? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 28.12%
Hepatic Failure (liver failure): 8 people, 25.00%
Anaemia (lack of blood): 7 people, 21.88%
Pain: 7 people, 21.88%
Pleural Effusion (water on the lungs): 6 people, 18.75%
High Blood Pressure: 5 people, 15.62%
Weight Decreased: 5 people, 15.62%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 15.62%
Haemoglobin Decreased: 5 people, 15.62%
Nausea (feeling of having an urge to vomit): 5 people, 15.62%

What are the existing conditions these people have? *

Pain: 6 people, 18.75%
Nausea (feeling of having an urge to vomit): 6 people, 18.75%
Hepatic Neoplasm Malignant (liver cancer): 6 people, 18.75%
Diarrhea: 5 people, 15.62%
Type 2 Diabetes: 4 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 12.50%
Constipation: 4 people, 12.50%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 4 people, 12.50%
Abdominal Pain: 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and have Hepatic encephalopathy?

- Check whether Hepatic encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sucralfate:

Sucralfate (17,548 reports)

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic encephalopathy:

Hepatic encephalopathy (910 drugs)

Browse all the conditions that are associated with Hepatic encephalopathy:

Hepatic encephalopathy (1,264 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate (the active ingredients of Sucralfate) and Sucralfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.